| 59.44 -2.45 (-3.96%) | 03-10 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 85.77 | 1-year : | 100.44 |
| Resists | First : | 73.43 | Second : | 86 |
| Pivot price | 62.04  |
|||
| Supports | First : | 53.11 | Second : | 44.18 |
| MAs | MA(5) : | 62.22 |
MA(20) : | 62.34 |
| MA(100) : | 88.13 |
MA(250) : | 109.31 |
|
| MACD | MACD : | -4 |
Signal : | -5  |
| %K %D | K(14,3) : | 14.8 |
D(3) : | 21.4 |
| RSI | RSI(14): 35.8 |
|||
| 52-week | High : | 176.44 | Low : | 53.11 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ INSP ] has closed above bottom band by 27.8%. Bollinger Bands are 63.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 10 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 62.39 - 62.74 | 62.74 - 63.12 |
| Low: | 57.9 - 58.28 | 58.28 - 58.69 |
| Close: | 58.72 - 59.38 | 59.38 - 60.1 |
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Mon, 09 Mar 2026
A Look At Inspire Medical Systems (INSP) Valuation After Strong Earnings Beat And Guidance Raise - simplywall.st
Mon, 09 Mar 2026
Inspire Medical Systems (INSP): Should You Buy, Sell, or Hold After Q4 Results? - Bitget
Mon, 09 Mar 2026
Inspire Medical Systems, Inc. $INSP Shares Purchased by WINTON GROUP Ltd - MarketBeat
Sun, 08 Mar 2026
Regal Partners Ltd Buys New Holdings in Inspire Medical Systems, Inc. $INSP - MarketBeat
Sun, 08 Mar 2026
Inspire Medical Systems (INSP): Buy, Sell, or Hold Post Q4 Earnings? - StockStory
Sat, 07 Mar 2026
Neo Ivy Capital Management Boosts Holdings in Inspire Medical Systems, Inc. $INSP - MarketBeat
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 29 (M) |
| Shares Float | 27 (M) |
| Held by Insiders | 1.7 (%) |
| Held by Institutions | 120.8 (%) |
| Shares Short | 3,940 (K) |
| Shares Short P.Month | 2,950 (K) |
| EPS | 4.88 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 27.32 |
| Profit Margin | 15.9 % |
| Operating Margin | 17.1 % |
| Return on Assets (ttm) | 3.7 % |
| Return on Equity (ttm) | 19.7 % |
| Qtrly Rev. Growth | 12.1 % |
| Gross Profit (p.s.) | 27.23 |
| Sales Per Share | 31.89 |
| EBITDA (p.s.) | 2.27 |
| Qtrly Earnings Growth | 308.3 % |
| Operating Cash Flow | 117 (M) |
| Levered Free Cash Flow | 55 (M) |
| PE Ratio | 12.15 |
| PEG Ratio | 0 |
| Price to Book value | 2.17 |
| Price to Sales | 1.86 |
| Price to Cash Flow | 14.52 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|